We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
may represent an alternative early biomarker for the recurrence of low-grade gliomas.
No takes yet. Share an insight, caveat, or question.
Duan et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: